MED GEN INC NEW bald bei 1$ ????????????????? - 500 Beiträge pro Seite

[ecos]

MED GEN INC NEW bald bei 1$ ????????????????? aktuelle Marktkapit. gerade 2Mio US $

Update: September 14, 2004



To all shareholders:



I cannot foretell the future, nor can I change the past. However, you can surely bet that I will work hard to preserve what has been built over the past seven years. The news reports of the last few weeks can only portray a flash of our company, a short moment in time that becomes instant history. Still, I have done my best to convey the good and the bad, the bold and the serene, the positive and the negative While it is true that Med Gen is going through the undulating rigors of a post trial loss, you must be aware that the atmosphere, much to the credit of our staff, is one of business as usual.



The Justice system is at times unjust. I still smart over how the legitimate firing of our former distributors, which was due to the failed promise of millions of dollars in orders and the re-assigning of brokers to an alien company without a single notice, could have turned into this prolonged lawsuit. The legal costs of the trial alone exceeded $300,000. That a judgment award, made by a jury of six women (with little or no business experience) and one college aged man, could have awarded a judgment amount that is more than the entire profits gained from the one account that they claimed to have opened, is yet another example of a system gone awry.



Yet, I am told that there are safeguards built into the system and that is what we are now pursuing. Although I don’t believe in luck, I do believe in justice and I believe Med Gen will have its “day in court” and we will prevail. While this is going on we must take care of business. Recently the company has announced two major store openings, Meijers that has stores in Ohio, Wisconsin, Kentucky, Illinois and Gristedes, which is a “king” in the New York City area. There are several other important store openings that will be announced as they come on line. The goal is 40,000 outlets by the end of fiscal year 2005. As distribution increases our advertising budget will increase proportionately. Our recent advertising blitz featuring both TV and Radio commercials has proved to us the real power of advertising and how important it is to the success of any marketing program. The Rush Limbaugh Show was especially important to us.



As you also know, we have been pushing the international markets and we expect considerable activity from China and Europe. Time and money are the keys to success overseas. We have succeeded in winning our CE registration for the European Common Markets, TGF approval for Australia and KFDA approval for Korea… The process will continue and we should start shipping meaningful amounts into directed overseas markets as their stringent requirements are met. The process is not easy and it is costly, but the rewards are great.



Then there is the subject of our stock. As I read the chat room gossip I get the feeling of total confusion. It is largely true that stocks tend to positively react to buying support. However, it is undeniably true that in OTCBB stocks, the machinations by Market Makers, creating short positions and price fluctuations, have a great persuasion on the price. Day trading in “penny stocks” has become the game of choice for “chatters”. This too adds to the confusion of the markets and creates large swings. Yet, all agree that the greater persuasion towards the buy side and the result is a rapid upward trend. It is the very nature of Chat Rooms which create rapid buying and selling…. Not a good combination for long-term growth. Most “Chat Investors”, as I like to call them, cannot win as they rapidly move from one tout to another, selling and buying in a reckless manner. Do your homework! If you believe in our products, in our philosophy and in our management team, then take an initial position and add to it, averaging up or down as the case may be. Your investing results should certainly improve.



We are all equals as Shareholders. We are afloat in the same Ocean, all rising and falling with the waves together. It is not they and we… Only us, together. Why come out of this as a good company when we can be a great company. Med Gen does have this opportunity and I hope you can recognize this. After all, we are a company with great products, great distribution and great opportunities.



There is much to get done.



Respectfully,





Paul B. Kravitz

Chairman/CEO

[ecos]

Die letzten News zu MED GEN

Press Release Source: Med Gen Inc.


Meijer`s to Sell Med Gen`s Snorenz
Friday August 27, 8:30 am ET


BOCA RATON, Fla.--(BUSINESS WIRE)--Aug. 27, 2004--Med Gen Inc. (OTCBB:MDGN - News), manufacturers of the national brands Snorenz®, snore relief throat spray and Good Nights Sleep®, sleep aid throat spray, announced today that it has received purchase orders to ship Snorenz® to all Meijer`s 150 stores.
"This placement is extremely important to Med Gen`s growth since Meijer`s is a dominant retail force in the mid-west, specifically Michigan, Ohio, Illinois, Wisconsin and Kentucky," said Paul B. Kravitz, Chairman & CEO. Med Gen`s recent advertising campaigns have meant a lot to the brand`s success.

Meijer opened its first store in Michigan in 1962 and since then has grown into supercenters featuring over 40 departments in over 150 stores across the Midwest. The stores feature extraordinary selection, low prices and friendly service. They will now offer Snorenz® and snoring relief to all their thousands of customers.

The opening of other major retail chains throughout the United States will be announced by management for both Good Nights Sleep® and Snorenz® during September and October.

This Press Release contains or incorporates by reference "forward looking statements" including certain information with respect to plans and strategies of Med Gen Inc. For this purpose, any statements contained herein or incorporated herein by references that are not statements of historical fact may be deemed forward looking statements. Without limiting the foregoing, the words "believes", "suggests", "anticipates", "plans", "expects", and similar expressions are intended to identify forward looking statements. There are a number of events or actual results of Med Gen operations that could differ materially from those indicated by such forward looking statements.

Med Gen, Inc. is a publicly traded company on the OTCBB exchange "MDGN".

[ecos]

Med Gen Ready to Enter $2 Billion Analgesic Market
Monday August 30, 8:00 am ET


BOCA RATON, Fla.--(BUSINESS WIRE)--Aug. 30, 2004--Med Gen Inc. (OTCBB:MDGN - News), manufacturers of the national brands Snorenz®, snore relief throat spray and Good Nights Sleep®, sleep aid throat spray, announced today that it intends to make an early release on a new analgesic spray formula catering to both adults and children that find it difficult to take pills.
The "Spray`s the Way" technology that Med Gen has spearheaded these past 5 years is showing signs of enormous growth potential. Med Gen management believes that by taking ownership to this niche business it can successfully navigate its products onto the shelves of major retailers as an alternate to the large array of products that now compete in pill and caplet formats. The advantage to Med Gen`s throat spray technology is that it is easier to use, is absorbed quickly into the blood stream for maximum effect and caters to the "Pill Hater" population that just cannot swallow pills easily. Med Gen`s management has set its goal at a conservative 1% market share, which would mean an additional $20 million in sales. This goal could be achieved within 12-36 months of its entrance into the market.

Med Gen`s Painenz Spray(TM) will contain Ibuprofen, which is a nonsteroidal anti-inflammatory drug, more commonly classified as an NSAID. In effect, Painenz Spray(TM) will provide relief from pain, tenderness, inflammation and stiffness and will be used to treat osteoarthritis, rheumatoid arthritis, gout and even painful menstruation.

Med Gen`s "Spray`s The Way" unique delivery system provides the practical alternative to pills, caplets and syrups. The adult version has a pleasant fresh minty flavor and the easy to take children`s version will taste like fruity bubble gum.

This Press Release contains or incorporates by reference "forward looking" statements including certain information with respect to plans and strategies of Med Gen Inc. For this purpose, any statements contained herein or incorporated herein by references that are not statements of historical fact may be deemed forward looking statements. Without limiting the foregoing, the words "believes", "suggests", "anticipates", "plans", "expects", and similar expressions are intended to identify forward looking statements. There are a number of events or actual results of Med Gen operations that could differ materially from those indicated by such forward looking statements.

Med Gen, Inc. is a publicly traded company on the OTCBB exchange "MDGN".

[ecos]

Med Gen Lender Agrees to Capitalize Expansion of International Markets
Wednesday September 1, 8:00 am ET


BOCA RATON, Fla.--(BUSINESS WIRE)--Sept. 1, 2004--Med Gen Inc. (OTCBB:MDGN - News), manufacturers of the national brands Snorenz®, snore relief throat spray, and Good Nights Sleep®, sleep aid throat spray, announced today that it has reached an Agreement whereby Med Gen`s secured lender would help finance the distribution of Snorenz®/SnoreAway® and Good Nights Sleep(TM) into the lucrative international marketplace.
Med Gen had reported earlier its successes in winning the KFDA in Korea, the TGA approval in Australia, the contractual arrangement with Akora in France and our business in Turkey sponsored by Nutrition For Life International. Both Nutrition For Life and Akora (France) have gone out of business. Solurone®, the company`s French brand is now being distributed by Solurone LTD in France and Belgium. Furthermore Med Gen has effectively trademarked its European Brand SnoreAway® in all of the participating countries in the EU. Management intends to explore the viability of its products throughout Europe.

At one time, International business accounted for over $1M in sales and was rapidly growing. Med Gen management has since re-organized its efforts to distribute its brands in foreign markets. Recently, management has engaged with a group from China and Taiwan, after a 14 month process registering Med Gen`s trademarks, the marketing program is significant and would contribute greatly to Med Gen`s future growth but would require capital resources beyond its present capacity. "Receiving a vote of confidence in the way of financial support from its present lender all but assures our success in China as well as other International markets," said Paul Kravitz, Chairman & CEO.

Med Gen`s foreign expansion will include the following terms; a minimum pre-licensing fee of $50,000 per Brand. Management believes that with this new policy the company can insure long term relationships with legitimate overseas distributors and avoid the roller-coaster effect of Med Gen`s prior entree into these markets.

In addition, Med Gen has recently received its first order from Euro-Viro, its new Scandinavian distributor.

This Press Release contains or incorporates by reference "forward-looking statements," including certain information with respect to plans and strategies of Med Gen Inc. For this purpose, any statements contained herein or incorporated herein by references that are not statements of historical fact may be deemed forward looking statements. Without limiting the foregoing, the words "believes," "suggests," "anticipates," "plans," "expects," and similar expressions are intended to identify forward looking statements. There are a number of events or actual results of Med Gen operations that could differ materially from those indicated by such forward looking statements.

Med Gen, Inc. is a publicly traded company on the OTCBB exchange "MDGN."

[ecos]

Med Gen Inc. Files Motion for New Trial
Monday September 13, 8:30 am ET


BOCA RATON, Fla.--(BUSINESS WIRE)--Sept. 13, 2004--Med Gen Inc. (OTCBB:MDGN - News), manufacturers of the national brands Snorenz®, snore relief throat spray and Good Nights Sleep®, sleep aid throat spray, announced today that it has filed a "MOTION FOR NEW TRIAL" in its case with Global Healthcare Laboratories, Inc., the company`s former distributor. This lawsuit was reported by the company in an August 10, 2004 News Release to the public.
The Motion was filed pursuant to F.R.C.P. 59 (Federal Law Procedures). Supporting the motion, which requests a new trial on the present and future damage awards, is the "lack of evidence" and "speculative evidence" that support the Plaintiffs` claims.

In the August 10, 2004 News Release, the company erred in the manner that it reported the Jury awards. The company used the word punitive damages when, in fact, there were no punitive damage awards, only present and future damage awards. The Company, in an amended 8K filing with the Securities and Exchange Commission, reported this error. These awards are now being contested by the company on the basis that they were inappropriately awarded based upon Florida Law and other "case" law.

Management is committed to defending its corporate and shareholder rights in any legal venue that it can. Also, reported earlier, it is Management`s intention to file an Appeal when it becomes evident that an Appeal should be filed. Additionally, reportable events concerning this matter will be accurately conveyed to the public and the shareholders in a timely fashion through News Releases from the company.

As a matter of normal business, the company wishes to report that its sales from its largest customer continues to increase every month, which to a large extent is the result of its April to August advertising blitz. The company intends to continue its advertising campaign especially to support new store openings in Wisconsin, Kentucky, Ohio, Illinois and New York.

This Press Release contains or incorporates by reference "forward looking statements" including certain information with respect to plans and strategies of Med Gen Inc. For this purpose, any statements contained herein or incorporated herein by references that are not statements of historical fact may be deemed forward looking statements. Without limiting the foregoing, the words "believes", "suggests", "anticipates", "plans", "expects", and similar expressions are intended to identify forward looking statements. There are a number of events or actual results of Med Gen operations that could differ materially from those indicated by such forward looking statements.

Med Gen, Inc. is a publicly traded company on the OTCBB exchange "MDGN".

[js200]

09/13/2004 (08:45 ET) MDGN: Lender Agreement to Fund International Expansion - Knobias
09/13/2004 (08:30 ET) Med Gen Inc. Files Motion for New Trial - Business Wire
09/01/2004 (08:00 ET) Med Gen Lender Agrees to Capitalize Expansion of International Markets - Business Wire
09/01/2004 (04:54 ET) RumorAlerts.com: Stock Watch Alert for Wednesday, September 1, 2004: MDGN, PMDX, OCRI - M2 Communications
08/30/2004 (08:00 ET) Med Gen Ready to Enter $2 Billion Analgesic Market - Business Wire